Response to the comment on "Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients"
Br J Cancer
.
2020 Oct;123(9):1468.
doi: 10.1038/s41416-020-1014-4.
Epub 2020 Aug 3.
Authors
Oleg Blyuss
1
2
3
,
Tatjana Crnogorac-Jurcevic
4
Affiliations
1
School of Physics, Astronomy and Mathematics, University of Hertfordshire, Hatfield, UK. o.blyuss@qmul.ac.uk.
2
Department of Paediatrics and Paediatric Infectious Diseases, Sechenov First Moscow University, Moscow, Russia. o.blyuss@qmul.ac.uk.
3
Department of Applied Mathematics, Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod, Russia. o.blyuss@qmul.ac.uk.
4
Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
PMID:
32741972
PMCID:
PMC7591559
DOI:
10.1038/s41416-020-1014-4
No abstract available
Publication types
Letter
Comment
MeSH terms
Biomarkers
Early Detection of Cancer*
Humans
Mass Screening
Pancreatic Neoplasms* / diagnosis
Risk Factors
Substances
Biomarkers